Digital Biomarkers Market Size, Share, Growth & Industry Analysis, By Type (Wearable, Mobile Application, Others), By Application (Neurological Disorders, Respiratory Disease & Others), By Clinical Practices (Monitoring, Diagnostics, Prognostics), By End User and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL DIGITAL BIOMARKERS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL DIGITAL BIOMARKERS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE
6.1 Overview
6.2 Wearable
6.3 Mobile Application
6.4 Others

7 GLOBAL DIGITAL BIOMARKERS MARKET, BY APPLICATION
7.1 Overview
7.2 Neurological Disorders
7.3 Respiratory Disease
7.4 Others
7.5 Cardiovascular Disease
7.6 Diabetes

8 GLOBAL DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICES
8.1 Overview
8.2 Monitoring
8.3 Diagnostics
8.4 Progonostics

9 GLOBAL DIGITAL BIOMARKERS MARKET, BY END USER
9.1 Overview
9.2 Healthcare Providers
9.3 Healthcare Consumers
9.4 Others

10 GLOBAL DIGITAL BIOMARKERS MARKET, BY GEOGRAPHY
10.1 Overview

11 NORTH AMERICA 
11.1 U.S.
11.2 Canada
11.3 Mexico

12 EUROPE 
12.1 Germany
12.2 U.K.
12.3 France
12.4 Italy
12.5 Spain
12.6 Russia
12.7 Rest of Europe

13 ASIA-PACIFIC 
13.1 China
13.2 Japan
13.3 India
13.4 South Korea
13.5 Rest of Asia-Pacific

14 MIDDLE EAST & AFRICA 
14.1 GCC
14.2 South Africa
14.3 North Africa
14.4 Rest of Middle East & Africa

15 LATIN AMERICA 
15.1 Brazil
15.2 Argentina
15.3 Rest of South America

16 GLOBAL DIGITAL BIOMARKERS MARKET COMPETITIVE LANDSCAPE
16.1 Overview
16.2 Key Developments
16.3 Key Strategic Developments
16.4 Company Market Ranking
16.5 Regional Footprint
16.6 Industry Footprint

17 COMPANY PROFILES
17.1 AliveCor, Inc.
17.1.1 Key Facts
17.1.2 Financial Overview
17.1.3 Product Benchmarking
17.1.4 Recent Developments
17.1.5 Winning Imperatives
17.1.6 Current Focus & Strategies
17.1.7 Threat from competition
17.1.8 SWOT Analysis
17.2 Amgen Inc.
17.2.1 Key Facts
17.2.2 Financial Overview
17.2.3 Product Benchmarking
17.2.4 Recent Developments
17.2.5 Winning Imperatives
17.2.6 Current Focus & Strategies
17.2.7 Threat from competition
17.2.8 SWOT Analysis
17.3 Biogen
17.3.1 Key Facts
17.3.2 Financial Overview
17.3.3 Product Benchmarking
17.3.4 Recent Developments
17.3.5 Winning Imperatives
17.3.6 Current Focus & Strategies
17.3.7 Threat from competition
17.3.8 SWOT Analysis
17.4 Huma
17.4.1 Key Facts
17.4.2 Financial Overview
17.4.3 Product Benchmarking
17.4.4 Recent Developments
17.4.5 Winning Imperatives
17.4.6 Current Focus & Strategies
17.4.7 Threat from competition
17.4.8 SWOT Analysis
17.5 Koneska Health
17.5.1 Key Facts
17.5.2 Financial Overview
17.5.3 Product Benchmarking
17.5.4 Recent Developments
17.5.5 Winning Imperatives
17.5.6 Current Focus & Strategies
17.5.7 Threat from competition
17.5.8 SWOT Analysis
17.6 Evidation Health, Inc.
17.6.1 Key Facts
17.6.2 Financial Overview
17.6.3 Product Benchmarking
17.6.4 Recent Developments
17.7 Eli Lilly and Company
17.7.1 Key Facts
17.7.2 Financial Overview
17.7.3 Product Benchmarking
17.7.4 Recent Developments
17.8 Pfizer Inc.
17.8.1 Key Facts
17.8.2 Financial Overview
17.8.3 Product Benchmarking
17.8.4 Recent Developments
17.9 Novartis Pharmaceuticals Corporation.
17.9.1 Key Facts
17.9.2 Financial Overview
17.9.3 Product Benchmarking
17.9.4 Recent Developments
17.10 GSK plc.
17.10.1 Key Facts
17.10.2 Financial Overview
17.10.3 Product Benchmarking
17.10.4 Recent Developments

LIST OF TABLES 

TABLE 1 Global Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 2 Global Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 3 Global Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 4 Global Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 5 Global Digital Biomarkers Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 6 North America Digital Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 7 North America Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 8 North America Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 9 North America Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 10 North America Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 11 US Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 12 US Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 13 US Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 14 US Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 15 Canada Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 16 Canada Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 17 Canada Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 18 Canada Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 19 Mexico Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 20 Mexico Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 21 Mexico Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 22 Mexico Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 23 Europe Digital Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 24 Europe Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 25 Europe Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 26 Europe Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 27 Europe Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 28 Germany Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 29 Germany Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 30 Germany Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 31 Germany Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 32 France Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 33 France Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 34 France Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 35 France Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 36 U.K. Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 37 U.K. Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 38 U.K. Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 39 U.K. Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 40 Spain Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 41 Spain Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 42 Spain Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 43 Spain Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 44 Italy Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 45 Italy Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 46 Italy Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 47 Italy Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 48 Russia Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 49 Russia Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 50 Russia Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 51 Russia Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 52 Rest of Europe Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 53 Rest of Europe Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 54 Rest of Europe Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 55 Rest of Europe Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 56 Asia-Pacific Digital Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 57 Asia-Pacific Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 58 Asia-Pacific Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 59 Asia-Pacific Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 60 Asia-Pacific Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 61 China Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 62 China Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 63 China Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 64 China Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 65 Japan Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 66 Japan Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 67 Japan Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 68 Japan Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 69 India Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 70 India Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 71 India Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 72 India Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 73 South Korea Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 74 South Korea Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 75 South Korea Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 76 South Korea Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 77 Rest of Asia-Pacific Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 78 Rest of Asia-Pacific Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 79 Rest of Asia-Pacific Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 80 Rest of Asia-Pacific Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 81 Middle East and Africa Digital Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 82 Middle East and Africa Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 83 Middle East and Africa Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 84 Middle East and Africa Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 85 Middle East and Africa Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 86 GCC Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 87 GCC Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 88 GCC Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 89 GCC Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 90 North Africa Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 91 North Africa Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 92 North Africa Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 93 North Africa Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 94 South Africa Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 95 South Africa Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 96 South Africa Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 97 South Africa Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 98 Rest of Middle East & Africa Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 99 Rest of Middle East & Africa Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 100 Rest of Middle East & Africa Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 101 Rest of Middle East & Africa Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 102 Latin America Digital Biomarkers Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 103 Latin America Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 104 Latin America Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 105 Latin America Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 106 Latin America Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 107 Brazil Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 108 Brazil Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 109 Brazil Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 110 Brazil Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 111 Argentina Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 112 Argentina Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 113 Argentina Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 114 Argentina Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 115 Rest of Latin America Digital Biomarkers Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 116 Rest of Latin America Digital Biomarkers Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 117 Rest of Latin America Digital Biomarkers Market Revenue, By Clinical Practices, 2021 – 2031 (USD Million)
TABLE 118 Rest of Latin America Digital Biomarkers Market Revenue, By End User, 2021 – 2031 (USD Million)
TABLE 119 Company Market Ranking
TABLE 120 Regional Footprint
TABLE 121 Product Benchmarking
TABLE 122 Recent Developments
TABLE 123 Winning Imperatives

List of Figures 

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Digital Biomarkers Market 2021-2031 (USD Million)
FIG. 4 Global Digital Biomarkers Market Geographical Analysis (CAGR %)
FIG. 5 Global Digital Biomarkers Absolute Market Opportunity (USD Million)
FIG. 6 Global Digital Biomarkers Market Attractiveness (USD Million)
FIG. 7 Global Digital Biomarkers Market, By Type, 2021-2031 (USD Million)
FIG. 8 Global Digital Biomarkers Market, By Application, 2021-2031 (USD Million)
FIG. 9 Global Digital Biomarkers Market, By Clinical Practices, 2021-2031 (USD Million)
FIG. 10 Global Digital Biomarkers Market, By End User, 2021-2031 (USD Million)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 MARKET DYNAMICS OVERVIEW
FIG. 16 Porter's Five Forces Analysis
FIG. 17 VALUE CHAIN ANALYSIS
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Digital Biomarkers Market Revenue Share, By Type, 2021 and 2031 (%)
FIG. 20 Global Digital Biomarkers Market Revenue Share, By Application, 2021 and 2031 (%)
FIG. 21 Global Digital Biomarkers Market Revenue Share, By Clinical Practices, 2021 and 2031 (%)
FIG. 22 Global Digital Biomarkers Market Revenue Share, By End User, 2021 and 2031 (%)
FIG. 23 Global Digital Biomarkers Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 North America Digital Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Europe Digital Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Asia-Pacific Digital Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 31 Middle East & Africa Digital Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 33 Latin America Digital Biomarkers Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 34 Key Strategic Development
FIG. 35 Key Facts
FIG. 36 Financial Overview
FIG. 37 SWOT Analysis